Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supporting Career Transitions of Senior Faculty: Perspectives of Chairs and Full Professors.

The Journal of pediatrics·2023
Same author

Safety of a modified environmental rush immunotherapy protocol in the pediatric population.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2021
Same author

Regulation of Pulmonary Bacterial Immunity by Follistatin-Like Protein 1.

Infection and immunity·2020
Same author

The Follistatin-like Protein 1 Pathway Is Important for Maintaining Healthy Articular Cartilage.

ACR open rheumatology·2020
Same author

Evaluation of humoral immunity in end-stage lung disease.

The journal of allergy and clinical immunology. In practice·2020
Same author

FSTL-1 Attenuation Causes Spontaneous Smoke-Resistant Pulmonary Emphysema.

American journal of respiratory and critical care medicine·2019

Related Experiment Video

Updated: Jul 8, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Gene therapy for arthritis.

Russell S Traister1, Raphael Hirsch

  • 1Division of Rheumatology, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

Modern Rheumatology
|January 8, 2008
PubMed
Summary
This summary is machine-generated.

Gene therapy offers a promising new approach to treating arthritis, potentially overcoming limitations of current treatments. This review explores advancements in gene transfer strategies for arthritis, including delivery methods, vectors, genes, and safety considerations.

Related Experiment Videos

Last Updated: Jul 8, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Area of Science:

  • Biomedical Engineering
  • Molecular Medicine
  • Rheumatology

Background:

  • Arthritis is a primary cause of disability globally.
  • Current arthritis treatments offer limited efficacy and symptom relief.
  • Existing treatments face challenges due to short drug half-lives and systemic administration.

Purpose of the Study:

  • To review recent advancements in gene therapy for arthritis treatment.
  • To discuss the potential of gene transfer to overcome current therapeutic limitations.

Main Methods:

  • Review of recent scientific literature on gene therapy for arthritis.
  • Analysis of gene delivery strategies and vector systems.
  • Examination of candidate genes and safety profiles for arthritis gene therapy.

Main Results:

  • Gene transfer approaches present a novel strategy for arthritis management.
  • Various delivery methods, vectors, and candidate genes are being explored.
  • Safety considerations are crucial for the clinical application of gene therapy in arthritis.

Conclusions:

  • Gene therapy holds significant potential to revolutionize arthritis treatment.
  • Further research into delivery, vectors, genes, and safety is essential.
  • This approach may offer improved disease control and symptomatic relief for arthritis patients.